Samsung Bioepis Sees Information Driving Utilization
Quarterly US Report Offers Detailed Information To Help Drive Biosimilar Uptake
By offering a detailed quarterly report on the US biosimilars market, Samsung Bioepis is hoping to help drive awareness and understanding, ultimately pushing up utilization, the firm’s US head of market access Tom Newcomer tells Generics Bulletin.
